|
DENR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.197210E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.907810E-01 |
| Normal-vs-Stage2 |
1.711580E-01 |
| Normal-vs-Stage3 |
1.500640E-01 |
| Normal-vs-Stage4 |
6.448000E-01 |
| Stage1-vs-Stage2 |
5.343000E-01 |
| Stage1-vs-Stage3 |
5.966600E-01 |
| Stage1-vs-Stage4 |
5.736000E-01 |
| Stage2-vs-Stage3 |
8.607600E-01 |
| Stage2-vs-Stage4 |
3.680600E-01 |
| Stage3-vs-Stage4 |
4.093200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.773620E-01 |
| Normal-vs-AfricanAmerican |
4.437400E-03 |
| Normal-vs-Asian |
8.172000E-01 |
| Caucasian-vs-AfricanAmerican |
2.424400E-02 |
| Caucasian-vs-Asian |
8.431600E-01 |
| AfricanAmerican-vs-Asian |
2.451400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.543580E-01 |
| Normal-vs-Female |
1.615820E-01 |
| Male-vs-Female |
9.036000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.368590E-01 |
| Normal-vs-Age(41-60Yrs) |
2.315800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.266200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.023400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.751200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.137200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.624200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.668000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.609800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.443800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.359600E-01 |
| Normal-vs-Grade 2 |
6.478400E-01 |
| Normal-vs-Grade 3 |
1.366220E-02 |
| Normal-vs-Grade 4 |
3.491800E-01 |
| Grade 1-vs-Grade 2 |
9.134200E-01 |
| Grade 1-vs-Grade 3 |
3.667800E-01 |
| Grade 1-vs-Grade 4 |
7.062200E-01 |
| Grade 2-vs-Grade 3 |
2.348500E-02 |
| Grade 2-vs-Grade 4 |
5.285200E-01 |
| Grade 3-vs-Grade 4 |
4.125200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.402400E-01 |
| Normal-vs-ccB subtype |
4.524800E-01 |
| ccA subtype-vs-ccB subtype |
6.765200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.197400E-01 |
| Normal-vs-N1 |
8.269200E-01 |
| N0-vs-N1 |
5.197400E-01 |
|
|
